These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 8759179

  • 1. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J, Keliner K, Zilkens T, Schmidt-Gayk H, Selisko T, Scholz GH.
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [Abstract] [Full Text] [Related]

  • 2. Low plasma growth hormone binding protein in IDDM.
    Mercado M, Molitch ME, Baumann G.
    Diabetes; 1992 May; 41(5):605-9. PubMed ID: 1568530
    [Abstract] [Full Text] [Related]

  • 3. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus.
    Clayton KL, Holly JM, Carlsson LM, Jones J, Cheetham TD, Taylor AM, Dunger DB.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):517-24. PubMed ID: 7955462
    [Abstract] [Full Text] [Related]

  • 4. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Oct; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT, Barrios V, Pozo J, Argente J.
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [Abstract] [Full Text] [Related]

  • 6. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P, Brismar K, Rosenfeld RG, Hall K.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 8. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A, Brismar K, Degerblad M, Thorén M, Hall K.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [Abstract] [Full Text] [Related]

  • 9. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG, Ropelato MG, Domené HM, Pennisi P, Heinrich JJ, Jasper HG.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D, Walker JL, Adam E, Moatsstaats B, Mulumba N, Ketelslegers JM, Underwood LE.
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [Abstract] [Full Text] [Related]

  • 17. Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
    Ismail IS, Miell JP, Scanlon MF, Peters JR.
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):147-52. PubMed ID: 7535669
    [Abstract] [Full Text] [Related]

  • 18. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C, Duron F, Binoux M.
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [Abstract] [Full Text] [Related]

  • 19. Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3.
    Pirazzoli P, Cacciari E, De Iasio R, Pittalis MC, Dallacasa P, Zucchini S, Gualandi S, Salardi S, David C, Boschi S.
    Arch Dis Child Fetal Neonatal Ed; 1997 Sep; 77(2):F100-4. PubMed ID: 9377129
    [Abstract] [Full Text] [Related]

  • 20. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
    Amit T, Youdim MB, Hochberg Z.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.